What s The Job Market For ADHD Medication Pregnancy Professionals
From Shiapedia
ADHD Medication During Pregnancy and Breastfeeding
Women with ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how long-term exposure to these medications could affect the fetus.
A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality studies.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medication should evaluate the benefits of using it against the possible risks to the fetus. Doctors don't have the necessary data to provide clear recommendations, but they can provide information on risks and benefits that aid pregnant women in making informed choices.
A study published in Molecular Psychiatry found that women who used cheapest adhd medication medications during early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. The researchers used a large, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to eliminate any bias.
The study of the researchers was not without limitations. Researchers were unable in the beginning to differentiate the effects of the medication from the disorder. This makes it difficult for researchers to establish whether the few associations observed between the exposed groups were due to the use of medication or if they were confounded by the presence of comorbidities. The researchers also did not study the long-term effects for the offspring.
The study found that babies whose mothers took adhd medication pregnancy - click this link now - medication for adhd and depression during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to those whose mothers did not use any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.
Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases didn't appear to be influenced by the type of medication that was used during pregnancy.
The researchers suggest that the small risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit for both mother and child of continued treatment for the woman's condition. Doctors should discuss with their patients about this issue and try to help them improve coping skills which could reduce the impact of her disorder in her daily life and relationships.
Medication Interactions
Many doctors are confronted with the dilemma of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, doctors have to consider their own expertise and experience, as well as the experiences of other doctors, and the research that has been conducted on the subject.
Particularly, the subject of potential risks for the baby can be tricky. Many of the studies on this issue are based on observations rather than controlled research and their conclusions are often contradictory. Most studies focus on live-births, which could underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these issues by analyzing both information on deceased and live births.
The conclusion is that while some studies have found an association between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship and the majority of studies demonstrate a neutral or slightly negative effect. In each case an in-depth study of the risks and benefits should be conducted.
For many women with ADHD, the decision to stop medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. Additionally, the loss of medication can affect the ability to complete job-related tasks and drive safely, which are important aspects of a normal life for a lot of people with ADHD.
She suggests that women who aren't sure whether to continue taking medication or discontinue it due to pregnancy educate family members, coworkers, and friends about the condition, its impact on daily functioning and the benefits of continuing the current treatment regimen. Educating them can also aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can pass through the placenta. If a woman decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug could be transferred to the baby.
Risk of Birth Defects
As the use and abuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing as does the concern about the potential adverse effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers utilized two massive datasets to analyze more than 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.
The researchers of the study did not find any association between early use of medication and other congenital anomalies like facial deformities or club feet. The results are in agreement with previous studies which showed a small, but significant increase in cardiac malformations for women who began taking concerta adhd medication medication before the birth of their child. The risk was higher in the latter half of pregnancy, when a lot of women begin to discontinue their medication.
Women who used ADHD medications during the first trimester of pregnancy were also more likely to experience caesarean section, low Apgar score after delivery and a baby who needed help breathing at birth. However, the authors of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical issues that could have contributed to these findings.
Researchers hope that their research will help doctors when they encounter pregnant women. They recommend that, while discussing the risks and benefits is crucial, the decision to stop or keep treatment should be based on the woman's needs and the severity of her ADHD symptoms.
The authors also caution that even though stopping the medication is an option, it is not an option that is recommended due to the high rate of depression and other mental health problems among women who are pregnant or who are recently postpartum. Additionally, research suggests that women who stop taking their medication will have a tough adjustment to life without them once the baby is born.
Nursing
The responsibilities of a new mother can be overwhelming. Women suffering from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to new routines. Many women decide to continue taking their ADHD medication during pregnancy.
The risk for breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk at a low level. The rate of medication exposure will vary based on the dosage, frequency of administration and the time of day. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't fully known.
Because of the lack of research, some physicians may be inclined to discontinue stimulant medications during a woman's pregnancy. It's a difficult choice for the woman who must weigh the benefits of continuing her medication against the risks to the foetus. Until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal time.
A increasing number of studies have shown that most women can safely continue to take their ADHD medication during pregnancy and breastfeeding. In response, a rising number of patients are opting to continue their medication. They have found, in consultation with their physicians, that the benefits of keeping their current medication outweigh any risk.
It is crucial for women suffering from adhd sleep medication list who are considering breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also needed to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also learn about treatment options and build the coping mechanisms. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and the child, monitoring of indicators of deterioration, and, if needed modifications to the medication regimen.
